Systemic inflammation in recessive dystrophic epidermolysis bullosa: a 5-year longitudinal study
British Journal of Dermatology · 23.06.2026 · 195 (1) · 146-157
DOI: 10.1093/bjd/ljag082 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 05.03.2026. Verfasst von Meropi Karakioulaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Faculty of Medicine and Medical Center, University Hospital Freiburg, Germany. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background
Recessive dystrophic epidermolysis bullosa (RDEB) is characterized by skin fragility, extensive wounding and systemic complications. While inflammation contributes to disease severity, its pattern, longitudinal dynamics and clinical correlates remain poorly defined.
Objectives
To characterize the course of systemic inflammatory markers over time in patients with RDEB and explore their associations with clinical, microbiological and laboratory parameters.
Methods
This retrospective longitudinal study analysed the clinical and laboratory data of 120 visits within 5 years from 44 patients with intermediate (n = 22) and severe (n = 22) RDEB. Acute-phase proteins [C-reactive protein (CRP), interleukin (IL)-6, serum amyloid A (SAA)], neutrophil-to-lymphocyte ratio (NLR), leucocytes, thrombocytes and ferritin were examined in relation to wound body surface area, mucosal involvement, collagen VII (C7) protein expression levels, squamous cell carcinoma (SCC) presence, nutritional status, anaemia markers, wound microbiology and immunoglobulins.
Results
Individuals with severe RDEB showed an early and sustained systemic inflammatory profile, with CRP, IL-6 and SAA elevated > 3.5-fold from early childhood, plateauing in mid-adulthood. People with intermediate RDEB maintained low inflammatory activity throughout their lives. Acute-phase proteins and NLR were significantly elevated in the presence of SCC (CRP: P < 0.001; IL-6: P = 0.002; SAA: P = 0.01; NLR: P = 0.004), C7 absence (CRP: P = 0.002), and colonization by Pseudomonas (CRP and IL-6: P < 0.001) or fungi (CRP: P = 0.006). CRP and age were the most robust independent predictors of SCC risk. Streptococcus, Pseudomonas, fungi or polymicrobial colonization were associated with a broader systemic inflammatory response when compared with Staphylococcus infections. Hypoalbuminaemia and elevated immunoglobulins correlated with inflammatory markers and anaemia of chronic disease was reflected by declining iron and increased ferritin levels. In multivariable models, reduced C7 expression, wound burden and SCC were the strongest independent predictors of acute-phase inflammation.
Conclusions
This study reveals that severe RDEB involves early-onset, progressive systemic inflammation that peaks in mid-adulthood and then plateaus, suggesting a critical window for therapeutic intervention. In contrast, intermediate RDEB shows minimal systemic inflammation. The findings support a three-tiered treatment approach – wound burden reduction through curative or corrective interventions, antimicrobial strategies and anti-inflammatory therapy – aligned with standard of care and nutritional supplementation. An author video to accompany this article is available online.
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Faculty of Medicine and Medical Center, University Hospital Freiburg, Germany.
- Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Germany.
ORCID-Profile: Meropi Karakioulaki, Cristina Has
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Karakioulaki, M., Yang, H., Hess, M., Binder, H., Eyerich, K., & Has, C. (2026). Systemic inflammation in recessive dystrophic epidermolysis bullosa: a 5-year longitudinal study. British Journal of Dermatology, 195(1), 146-157. https://doi.org/10.1093/bjd/ljag082
Vancouver
Karakioulaki M, Yang H, Hess M, Binder H, Eyerich K, Has C. Systemic inflammation in recessive dystrophic epidermolysis bullosa: a 5-year longitudinal study. British Journal of Dermatology. 2026;195(1):146-157. doi:10.1093/bjd/ljag082
BibTeX
@article{Karakioulaki2026,
author = {Karakioulaki, Meropi and Yang, Hanning and Hess, Moritz and Binder, Harald and Eyerich, Kilian and Has, Cristina},
title = {Systemic inflammation in recessive dystrophic epidermolysis bullosa: a 5-year longitudinal study},
journal = {British Journal of Dermatology},
year = {2026},
volume = {195},
number = {1},
pages = {146--157},
doi = {10.1093/bjd/ljag082}
}
EUVIMED